HelixlyAI Genome Report Prepared for Sample Subject
Report ID HX-2026-0042 · synthetic
Immunity & Allergy · Document 15 of 24

Allergy & Histamine

How Sample Subject's histamine-degradation and skin-barrier variants may relate to intolerance and allergy patterns. All values below are synthetic.

3 findings2 Tier 2Reviewed 2026-01-15

Provenance

Data Provenanceverified chain
Document
Allergy & Histamine
Source assembly
GRCh37 (hg19)
Source file SHA-256
0000a1b2c3d4e5f6…4b5c6d7e
Supersedes
prior v1 · SHA 1111f0e9…
Evidence sources
CPIC, dbSNP, PubMed
Access date
2026-01-15

Provider Alert

Considerations — Provider Ready2 items · clinical correlation advised
ConsiderationGene / GenotypeEvidenceRecommendationSource
Dietary histamineAOC1 (DAO)
(rs0021101 GT)
ModerateReduced degradation — a supervised low-histamine trial may clarify symptoms.PubMed ↗
Antihistamine responseHNMT
(rs0021201 CT)
LimitedAltered intracellular clearance — monitor symptomatic response to therapy.dbSNP ↗

Per-Gene Findings

Filter:

AOC1 (DAO) — Reduced Histamine Degradation

Diamine oxidase · gut histamine breakdown
ModerateTier 2
rs00211017:150,800,000GT

Heterozygous genotype associated with reduced diamine-oxidase activity, the main enzyme degrading dietary histamine in the gut. May contribute to histamine-intolerance-type symptoms in some individuals.

Historical contextEarlier panel reported this under the legacy gene symbol; current annotation uses the approved symbol at access date.

HNMT — Reduced Methylation Clearance

Histamine N-methyltransferase · intracellular clearance
LimitedTier 2
rs00212012:138,700,000CT

Variant associated with modestly reduced HNMT activity, a secondary route of histamine clearance. Evidence for clinical impact in isolation is limited.

FLG — Skin-Barrier Variant

Filaggrin · epidermal barrier
LimitedTier 3
rs00213011:152,300,000CT

Carrier of one barrier-associated allele, reported for transparency. Evidence is insufficient to support a recommendation from genotype alone.

Genotype Table

Variants evaluated in this document — synthetic
rsIDchr:posGenotypeGeneSignificance
rs00211017:150,800,000GTAOC1Tier 2
rs00212012:138,700,000CTHNMTTier 2
rs00213011:152,300,000CTFLGTier 3
Consult your prescribing clinician. This HelixlyAI report is a synthetic demonstration generated from a consumer DNA export. Every name, identifier, rsID, genotype, and citation shown is fictional. It is not a diagnosis or medical advice — do not start, stop, or change any medication or treatment based on this document.